GSK-852

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGSK-852
Drug Alias NameGSK-852
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcUniversity Of Strathclyde
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of StrathclydeGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A